Skip to main content

GLOBAL TECHNOLOGIES LTD

For the period ended Sep 30, 2025. Filed Jan 20, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Jan 20, 2026

GTLLStored price and day change unavailable

What changed in Management’s Discussion and Analysis?

Read the current filing

Previous report: 10-Q

Period ended 2025-03-31; filed 2025-05-14.

0001641172-25-010291

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Current report: 10-Q

Period ended 2025-09-30; filed 2026-01-20.

0001493152-26-002920

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 88 previous paragraphs and 79 current paragraphs.

32 unchanged; 13 reworded; 34 added; 41 removed; 2 previous and 0 current paragraphs rearranged.

Tables are not compared: 5 previous and 2 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Added paragraphs (34)

Current report

Global Technologies, Ltd is a multi-operational company with a strong desire to drive transformative innovation and sustainable growth across the technology and service sectors, empowering businesses and communities through advanced, scalable solutions that enhance connectivity, efficiency, and environmental stewardship. The Company envisions a future where technology seamlessly integrates into every aspect of life, improving the quality of life and the health of the planet. Our vision is to lead the industries we serve with groundbreaking initiatives that set new standards in innovation, customer experience, and corporate responsibility, thereby creating enduring value for all shareholders.

Current report

Primecare Supply, LLC (“Primecare Supply”) was formed as a Wyoming limited liability company on October 22, 2024, and commenced operations in May 2025. Primecare Supply operates as a business-to-business (B2B) procurement company powered by the proprietary Sinq Ops software platform. The Company’s mission is to streamline and modernize the pharmaceutical supply chain by connecting fully licensed and compliant 503B pharmaceutical manufacturers with licensed medical clinics across the United States.

Current report

Primecare Supply facilitates these connections through both direct-to-clinic relationships and a network of authorized reseller partners. By leveraging its Sinq Ops technology, the Company provides secure, transparent, and fully compliant ordering, fulfillment, and payment workflows. Primecare Supply earns revenue on a per-transaction basis for facilitating these procurement activities.

Current report

Since launching operations, Primecare Supply has established contractual relationships with multiple 503B manufacturers, several reseller partners, and hundreds of licensed medical clinics actively utilizing the Sinq Ops procurement portal to manage their product supply needs.

Current report

Management believes Primecare Supply represents a core growth engine for Global Technologies, Ltd., offering scalable infrastructure, recurring transaction-based revenue, and a technology-enabled compliance advantage in the expanding health and wellness market.

Current report

GTLL Advisory Group, LLC (“GTLL Advisory”) was formed as a Wyoming limited liability company on May 20, 2025, as a wholly owned subsidiary of Global Technologies, Ltd. (“Global” or the “Company”). GTLL Advisory did not commence financial operations during fiscal year 2025.

Current report

GTLL Advisory, operating under the trade name GloWell Advisors, was established to serve as the Company’s strategic consulting and advisory platform. The subsidiary’s mission aligns with Global’s broader focus on advancing innovation and technology within the health and wellness industries.

Current report

GTLL Advisory’s purpose is to provide business transformation and value-enhancement services to small and mid-sized enterprises—particularly medical spas, wellness clinics, and professional service practices—through data-driven consulting, operational optimization, and access to technology resources developed within the Global ecosystem.

Current report

Rooted in Global’s commitment to building sustainable businesses that improve both human and organizational well-being, GTLL Advisory intends to combine strategy, technology, and financial insight to help clients achieve measurable growth and long-term stability.

Current report

Management expects GTLL Advisory to commence revenue-generating operations in fiscal year 2026 as part of Global’s expanding health-technology and advisory services portfolio.

Current report

During fiscal 2024, 10 Fold Services entered into agreements with a 503B pharmaceutical supplier to promote and facilitate the sale of GLP-1-based products under the FDA’s “shortage” provisions then in effect. In June 2025, following changes in FDA regulations and the expiration of the GLP-1 shortage allowance, the Company and its supplier mutually agreed to close all active contracts. As a result, 10 Fold Services ceased procurement operations and currently remains idle.

Current report

The limited liability company remains in good standing, though management has not yet determined its future direction. To preserve continuity across business lines, 10 Fold Services transferred—at no cost—certain intellectual property, including customer and supplier contacts and access to proprietary software systems, to Primecare Supply, LLC, another wholly owned subsidiary of Global Technologies, Ltd.

Current report

Management believes this transition allows Global to consolidate its resources and focus on expanding Primecare Supply’s operational and technology platforms within the broader health-and-wellness market

Current report

During fiscal 2025, Global determined that GOe3 had not met key operational and financial milestones required under the Share Exchange Agreement. As a result, Global elected to terminate and cancel the acquisition and all related agreements. The cancellation of the GOe3 transaction was previously disclosed on the Company’s Form 8-K filing on July 2, 2025 with reference to the Company’s Board Resolution passed by the Board of Directors on June 30, 2025.

Current report

Following the termination, Global wrote off its investment in GOe3 and all associated goodwill as of June 30, 2025. GOe3, LLC is no longer a subsidiary of Global Technologies, Ltd.

Current report

Management believes the decision to unwind the acquisition allowed Global to reallocate resources toward its core business segments in health technology, procurement, and strategic advisory services.

Current report

For the Three Months Ended September 30, 2025 Compared to the Three Months Ended September 30, 2024

Current report

The Company experienced a decrease in revenue for the three months ended September 30, 2025, as compared to the same period in 2024, primarily due to a strategic shift in the operating focus of its Primecare Supply subsidiary. During fiscal year 2025, the Company publicly disclosed changes occurring within the GLP-1 industry resulting from evolving FDA regulatory requirements impacting production and supply dynamics. During this transition period, the Company’s subsidiary, 10 Fold Services, served as the sole source of revenue and operated primarily as a wholesale procurement agent reliant on a single supplier.

Current report

Since that time, the Company has intentionally transitioned away from a predominantly wholesale model toward a direct-to-clinic sales strategy. While this shift has resulted in lower initial gross revenue volumes, it provides the Company with ownership of client relationships and data, improved supply-chain control, a more diversified product offering, and higher expected gross margins. As of September 30, 2025, Primecare Supply employed six direct-to-clinic account representatives and one director overseeing daily operations. Management believes this transition will result in slower near-term revenue growth but is designed to generate more sustainable revenue, improved margins, stronger free cash flow, and long-term shareholder value as sales volumes scale and mature.

Current report

Selling, general and administrative expenses were $65,774 and $42,984 for the three months ended September 30, 2025 and 2024, respectively, representing an increase of $22,790, or 53.02%.

Current report

Other Income (expenses) were $274,413 and ($10,095) for the three months ended September 30, 2025 and 2024, respectively, representing an increase in other income of $285,408. The other (expenses) for the three months ended September 30, 2025 and 2024 was made up of interest expense.

Current report

For the three months ended September 30, 2025, net income was $166,199 as compared to net income of $262,547 for three months ended September 30, 2024, a decrease of $96,348.

Current report

We had cash used in operating activities of ($115,031) for the three months ended September 30, 2025, compared to new cash provided by operating activites of $217,114 for the three months ended September 30, 2024. The net cash used in operating activities for the three months ended September 30, 2025 consisted primarily of net income of $166,199 offset by a gain on derivative liability in the amount of $282,000, security deposit of $4,221 and accounts payable of $2,571.

Current report

We had cash provided by investing activities of $- and $- for the three months ended September 30, 2025 and 2024, respectively.

Current report

We had cash (used in) provided by financing activities of $0 and ($40,000) for the three months ended September 30, 2025 and 2024, respectively, of which $40,000 was for payments against convertible notes payable during the three months ended September 30, 2024.

Current report

Known Trends, Events, Uncertainties and Factors That May Affect Future Operations

Current report

The impact of general economic conditions, actual and projected, including inflation, rising interest rates, lower consumer confidence, volatile capital markets, supply chain disruptions, uncertainty and volatility in the financial services sector and the impact of the Hamas-Israel and Russia-Ukraine conflicts, and government and business responses thereto, on the global economy and regional economies.

Current report

The Company has no debt covenants that require certain financial information to be met.
Removed paragraphs (41)

Previous report

Global Technologies, Ltd. is committed to delivering transformative innovation by aligning our investments with evolving consumer demand and high-potential growth sectors. While our legacy strategy included a dual focus on health and wellness through 10 Fold Services and electric vehicle (EV) infrastructure via GOe3, we have recently realigned our capital allocation and strategic priorities to reflect current market conditions and emerging opportunities.

Previous report

The EV charging industry is undergoing significant consolidation and competitive saturation, prompting Global to reassess the long-term viability of our involvement through GOe3. As a result, we are limiting further investment of time, energy, and capital into GOe3 and the EV infrastructure sector. This decision reflects not a retreat, but a disciplined pivot toward sectors where we see stronger consumer demand and clearer paths to profitability.

Previous report

Our health and wellness initiatives—anchored by 10 Fold Services and its affiliated operations—are now the core of Global’s strategic growth plan. These operations deliver strategic consulting, lead generation, and operational support to a rapidly growing network of wellness clinics, medical spas, and health service providers. By focusing on this vibrant and resilient sector, we believe we are positioning Global Technologies to deliver greater long-term value to our shareholders.

Previous report

As a versatile entity that functions as a service provider, SaaS platform, and outsourced sales force, 10 Fold Services is committed to delivering tailored solutions that enable businesses to achieve significant market presence and sustainable growth.

Previous report

One of 10 Fold Services’ initial clients operates in the medical sector, focusing on weight loss and fitness. Through a strategic blend of cutting-edge technologies and traditional sales techniques, 10 Fold Services has successfully assisted this client in penetrating the market and building a strong foundation for growth. The Company plans to maintain and deepen this relationship, using key insights to support other clients with similar objectives.

Previous report

10 Fold is also amassing a valuable repository of customer data, collected through its marketing and engagement efforts. This growing database serves both internal development and external client initiatives—enabling data-driven strategies that sharpen competitive advantage and enhance client outcomes.

Previous report

On November 23, 2023, 10 Fold Services entered into a Sales Agent Agreement with a supplier of pharmaceutical products, acting as a non-exclusive Sales Agent. Under this agreement, 10 Fold informs and educates potential customers and facilitates product sales, earning commissions based on volume. Additionally, on December 3, 2023, the Company entered into a profit-sharing Operating Agreement with a third-party contractor to execute pharmaceutical sales through industry connections, splitting profits equally after approved expenses.

Previous report

In early 2025, 10 Fold Services encountered a temporary disruption following the FDA’s recent ruling in favor of pharmaceutical manufacturers Eli Lilly and Novo Nordisk. This ruling paused the Company’s wholesale sales channel for GLP-1 medications, pending further regulatory clarification.

Previous report

In response, 10 Fold is actively pivoting to adapt to the evolving market. Drawing on its human capital, software investments, and strategic partnerships, the Company is shifting its model toward direct-to-consumer (DTC) pharmaceutical sales. This pivot reflects months of preparation and collaboration with technology providers to establish a scalable, compliant, and consumer-focused revenue channel.

Previous report

Despite the regulatory pause, 10 Fold remains agile, forward-looking, and committed to unlocking long-term value for its clients, partners, and shareholders.

Previous report

On June 8, 2023, GOe3 entered into an Earnest Money Agreement with a third party for the anticipated delivery of 1,000 home bi-directional chargers with grid-sensing capabilities and up to 1,000 workplace chargers, totaling approximately $10,000,000 in projected revenue.

Previous report

Despite these promising developments, GOe3 has faced significant operational and market headwinds. The company has been unable to complete key software development projects required to support the back-end of its EV charging network, limiting its ability to meet the compliance and performance standards necessary to secure government-sector contracts. Additionally, recent changes in U.S. federal policy regarding EV infrastructure funding, grants, and tax incentives have created further uncertainty and impeded market entry.

Previous report

As a result of these challenges, and in light of delays by GOe3’s management in executing critical milestones—including the completion of its platform software and government contracting readiness—Global Technologies, LTD has made the strategic decision to reduce its business investment in GOe3. Accordingly, the Company will also reassess and reduce the goodwill value previously assigned to the GOe3 acquisition as of March 15, 2024.

Previous report

Global Technologies, LTD remains committed to a disciplined capital allocation strategy and will continue to evaluate the performance of its subsidiaries to ensure alignment with long-term shareholder value creation.

Previous report

For more information, please refer to NOTE E – ACQUISITION OF GOe3, LLC.

Previous report

Foxx Trot Tango, LLC (“Foxx Trot”) was formed as a Wyoming limited liability company on February 3, 2022, and was acquired through a membership interest purchase agreement on July 25, 2023. Foxx Trot previously held title to a commercial building located in Sylvester, Georgia, which was sold on March 26, 2024. Following the completion of that transaction, the Company elected to dissolve Foxx Trot and does not intend to utilize the entity for any future real estate acquisitions or operations.

Previous report

Three months ended March 31, 2025 compared to three months ended March 31, 2024

Previous report

Selling, general and administrative expenses were $27,458 and $62,981 for the three months ended March 31, 2025 and 2024. The Company’s operating expenses are largely attributable to executive compensation and professional services for the three months ended March 31, 2025.

Previous report

Other Expenses– Interest expense for the three months ended March 31, 2025 was $5,908, compared to $44,049 for the same period in the prior year. Additional other expenses for the three-month period ended March 31, 2025 included losses related to derivative liabilities and the amortization of debt discounts.

Previous report

Net income (loss) for the three months ended March 31, 2025 and March 31, 2024 were ($193,197) and $2,756,900, respectively.

Previous report

Nine months ended March 31, 2025 compared to nine months ended March 31, 2024

Previous report

For the nine months ended March 31, 2025 and 2024, we generated revenue of $2,588,452 and 451,509, respectively.

Previous report

For the nine months ended March 31, 2025 and 2024, cost of revenues was $1,684,337 and $364,199, respectively.

Previous report

For the nine months ended March 31, 2025 and 2024, gross profit was $904,115 and $87,310, respectively.

Previous report

Selling, general, and administrative expenses were $97,572 and $122,236 for the nine months ended March 31, 2025 and 2024, respectively, representing a decrease of $24,664. However, the Company experienced significant increases in consulting and marketing expenses. For the same nine-month periods, consulting and marketing expenses rose from $252,818 in 2024 to $359,015 in 2025—an increase of $106,197. Officer and director compensation also increased, driven by the expansion of the executive team. Compensation for officers and directors totaled $135,183 for the nine months ended March 31, 2025, compared to $75,000 for the same period in 2024, representing an increase of $60,183.

Previous report

Overall, the Company’s operating expenses for the nine months ended March 31, 2025, were primarily driven by executive compensation, consulting services, software fees, travel, and marketing initiatives. These expenditures reflect strategic investments in leadership, business development, and operational infrastructure intended to support long-term growth. Executive compensation supports leadership efforts in executing strategic priorities, while consulting services have been used to enhance sales operations, financial planning, and technological development. Software fees reflect investments in automation, analytics, and customer management systems aimed at increasing efficiency and scalability. Travel expenses were incurred to support business development, investor relations, and partnership expansion. Marketing expenditures were focused on building brand awareness, acquiring new customers, and strengthening market positioning. Collectively, these investments are intended to drive continued revenue growth, improve operational efficiency, and reinforce the Company’s market presence.

Previous report

For the nine months ended March 31, 2025, the Company recorded other expenses of ($24,978), compared to other income of $940,570 for the same period in 2024. This represents a decrease of $965,548, or approximately 102.66%. The decline is attributable to the absence of one-time gains recognized in the prior year, including forgiveness of debt ($102,616), gain on sale of assets ($180,378), and a gain on derivative liability ($1,545,336), all of which were not repeated in the current period. Additionally, interest expense decreased significantly from ($195,157) in 2024 to ($24,978) in 2025. The Company also recognized no amortization of debt in the current period, compared to ($692,603) in 2024.

Previous report

Net income for the nine months ended March 31, 2025 was $250,059, compared to $526,230 for the same period in 2024, representing a decrease of $276,171, or 52.48%. While the Company experienced a substantial increase in revenue and gross profit due to growth in its 10 Fold Services subsidiary, the decline in net income was primarily the result of the non-recurrence of substantial one-time gains reported in the prior period’s other income.

Showing the first 40 of 41 passages. Open the source sections for the rest.

Reworded paragraphs (13)

Previous wording

Global Technologies, Ltd. (hereinafter the “Company”, “Our”, “We”, or “Us”) was incorporated under the laws of the State of Delaware on January 20, 1999 under the name of NEW IFT Corporation. On August 13, 1999, the Company filed an Amended and Restated Certificate of Incorporation with the State of Delaware to change the name of the corporation to Global Technologies, Ltd.

Current wording

Global Technologies, Ltd (“Global Technologies”) was incorporated under the laws of the State of Delaware on January 20, 1999 under the name of NEW IFT Corporation. On August 13, 1999, the Company filed an Amended and Restated Certificate of Incorporation with the State of Delaware to change the name of the corporation to Global Technologies, Ltd.

Previous wording

Our principal executive office is located at 806 Green Valley Road, Suite 200, Greensboro, North Carolina 27408 and our telephone number is (973) 233-5151. The information contained on, or that can be accessed through, our website is not a part of this Quarterly Report on Form 10-Q. We have included our website address in this Quarterly Report solely as an inactive textual reference.

Current wording

Our principal executive office is located at 806 Green Valley Road, Suite 200, Greensboro, North Carolina 27408 and our telephone number is (973) 233-5151. Our website address iswww.globaltechnologiesltd.info. The information provided on our website is not part of this Quarterly Report and is therefore not incorporated by reference unless such information is otherwise specifically referenced elsewhere in this Quarterly Report.

Previous wording

10 Fold Services, LLC (“10 Fold Services”) was formed as a Wyoming limited liability company on November 22, 2023. 10 Fold Services is a strategic consulting and procurement agency specializing in go-to-market planning and execution for companies in the health and wellness industries. Leveraging an “automation-first” approach, the Company skillfully combines internal and external resources to ensure cost-effective and impactful market introductions.

Current wording

10 Fold Services, LLC (“10 Fold Services”) was formed as a Wyoming limited liability company on November 22, 2023. 10 Fold Services was established as a strategic consulting and procurement agency focused on go-to-market planning and execution for companies in the health and wellness sector. Through an automation-first approach, 10 Fold Services integrated internal and external resources to deliver cost-effective and scalable marketing, sales, and technology solutions.

Previous wording

GOe3, LLC (“GOe3”) was formed as an Arizona limited liability company on February 12, 2000, and was acquired by Global Technologies, LTD (“GTLL”) through a Share Exchange Agreement on March 15, 2024. GOe3 was established to develop and operate a nationwide network of universal electric vehicle (“EV”) charging stations located within 45–75 miles of selected interstate highways across the United States. GOe3’s patent-pending charging station design combines Level 2 and Level 3 functionality and is supported by a platform integrating solar deployment, mobile applications, and business/consumer service portals.

Current wording

GOe3, LLC (“GOe3”) was formed as an Arizona limited liability company on February 12, 2000 and was acquired by Global Technologies, Ltd. (“Global” or the “Company”) pursuant to a Share Exchange Agreement executed on March 15, 2024. GOe3 was originally intended to develop and operate a network of universal electric vehicle (“EV”) charging stations positioned approximately every 45 to 75 miles along major U.S. interstate highways. The company’s platform was designed to include universal charging hardware, integrated solar deployment, and a proprietary travel and business portal supporting multiple revenue streams.

Previous wording

Since our inception on January 20, 1999, we have generated minimal revenue from our operations. We cannot guarantee we will be successful in our business operations. We have limited financial resources and limited operations until such time that we are able to begin to generate revenue from our own operations. Our business is subject to risks inherent in the establishment of a new business plan through the start-up of 10 Fold Services and subsequent acquisition of Goe3, including the financial risks associated with the limited capital resources currently available to us and risks associated with the implementation of our business strategies.

Current wording

Since our inception on January 20, 1999, we have generated minimal revenue from our operations. We cannot guarantee we will be successful in our business operations. We have limited financial resources and limited operations until such time that we are able to begin to generate revenue from our own operations. Our business is subject to risks inherent in the establishment of a new business plan through the start-up of our operating subsidiaries: 10 Fold Services, Primecare Supply, LLC and GTLL Advisory Group, LLC, including the financial risks associated with the limited capital resources currently available to us and risks associated with the implementation of our business strategies.

Previous wording

Selling, general and administrative expenses consist of selling, marketing, advertising, payroll, administrative, finance and professional expenses.

Current wording

Selling, general and administrative expenses consist of selling, marketing, advertising, administrative, finance and professional expenses.

Previous wording

The following table sets forth information comparing the components of net (loss) income for the three months ended March 31, 2025 and 2024:

Current wording

The following table sets forth information comparing the components of net income for the three months ended September 30, 2025 and 2024:

Previous wording

For the three months ended March 31, 2025 and 2024, we generated revenue of $1,001,944 and $451,509, respectively.

Current wording

For the three months ended September 30, 2025 and 2024, we generated revenue of $195,325 and $669,431, respectively. Our revenue for the three months ended September 30, 2025 was largely attributable to revenue generated through Primecare Supply.

Previous wording

For the three months ended March 31, 2025 and 2024, cost of revenues was $947,853 and $364,199, respectively.

Current wording

For the three months ended September 30, 2025 and 2024, cost of revenues was $98,397 and $191,889, respectively. The makeup of the cost of goods sold for the three months ended September 30, 2025 was entirely comprised of costs associated with the revenue derived from Primecare Supply

Previous wording

For the three months ended March 31, 2025 and 2024, gross profit was $53,991 and $87,310, respectively.

Current wording

For the three months ended September 30, 2025 and 2024, gross profit was $96,928 and $477,542, respectively.

Previous wording

The following table summarizes the cash flows for the nine months ended March 31, 2025 and 2024:

Current wording

The following table summarizes the cash flows for the three months ended September 30, 2025 and 2024:

Previous wording

As of March 31, 2025 and 2024, the Company had cash of $29,913 and $144,575 respectively.

Current wording

As of September 30, 2025 and 2024, the Company had cash of $152,977 and $292,861, respectively.

Previous wording

Neither inflation nor changing prices for the nine months ended March 31, 2025 had a material impact on our operations.

Current wording

Neither inflation nor changing prices for the three months ended September 30, 2025 had a material impact on our operations.
Rearranged previous paragraphs (2)

Previous report — wording carried elsewhere

The following table sets forth information comparing the components of net (loss) income for the nine months ended March 31, 2025 and 2024:

Previous report — wording carried elsewhere

There was no income tax expense for the nine months ended March 31, 2025 and March 31, 2024.